A randomized trial of protocol-based care for early septic shock

New England Journal of Medicine

Volumn 370, Issue 18, 2014, Pages 1683-1693

  Yealy, Donald M ^a   Kellum, John A ^a   Huang, David T ^a   Barnato, Amber E ^a   Weissfeld, Lisa A ^a   Pike, Francis ^a   Terndrup, Thomas ^b   Wang, Henry E ^c   Hou, Peter C ^d   LoVecchio, Frank ^e   Filbin, Michael R ^f   Shapiro, Nathan I ^g   Angus, Derek C ^h  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MARICOPA MEDICAL CENTER   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; HYPERTENSIVE FACTOR; INFUSION FLUID; OXYGEN; ANTIINFECTIVE AGENT; CARDIOTONIC AGENT; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; CENTRAL VENOUS PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; EMERGENCY WARD; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; RISK ASSESSMENT; SEPTIC SHOCK; TERTIARY HEALTH CARE; UNITED STATES; AGED; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CONTROLLED CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; FLUID THERAPY; MULTIMODALITY CANCER THERAPY; STANDARD;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BLOOD TRANSFUSION; CARDIOTONIC AGENTS; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; EMERGENCY SERVICE, HOSPITAL; FEMALE; FLUID THERAPY; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RESUSCITATION; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84899750488     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1401602     Document Type: Article

References (20)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10. (Pubitemid 32641789)
2. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-51. [Erratum, N Engl J Med 2013;369:2069.]
3. Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med 2007;35:1928-36. (Pubitemid 47220368)
4. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
5. Carlbom DJ, Rubenfeld GD. Barriers to implementing protocol-based sepsis resuscitation in the emergency department - results of a national survey. Crit Care Med 2007;35:2525-32. (Pubitemid 351339012)
6. Jones AE, Shapiro NI, Roshon M. Implementing early goal-directed therapy in the emergency setting: the challenges and experiences of translating research innovations into clinical reality in academic and community settings. Acad Emerg Med 2007;14:1072-8. (Pubitemid 47628816)
7. Reade MC, Huang DT, Bell D, et al. Variability in management of early severe sepsis. Emerg Med J 2010;27:110-5.
8. Pike F, Yealy DM, Kellum JA, et al. Protocolized Care for Early Septic Shock (ProCESS) statistical analysis plan. Crit Care Resusc 2013;15:301-10.
9. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73. [Errata, Crit Care Med 2004;32:1448, 2169-70.] (Pubitemid 38344143)
10. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327. [Erratum, Crit Care Med 2008;36:1394-6.]
11. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
12. Minneci PC, Eichacker PQ, Danner RL, Banks SM, Natanson C, Deans KJ. The importance of usual care control groups for safety monitoring and validity during critical care research. Intensive Care Med 2008;34:942-7.
13. A handbook for clinical investigators conducting therapeutic clinical trials supported by CTEP, DCTD, NCI. Bethesda, MD: National Cancer Institute CTEP, 2013.
14. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010; 303:739-46.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
16. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17. [Erratum, N Engl J Med 1999;340:1056.] (Pubitemid 29084771)
17. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
18. Rivers EP, Katranji M, Jaehne KA, et al. Early interventions in severe sepsis and septic shock: a review of the evidence one decade later. Minerva Anestesiol 2012;78:712-24.
19. Huang DT, Angus DC, Barnato A, et al. Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med 2013;39:1760-75.
20. Reade MC, Delaney A, Bailey MJ, et al. Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med 2010;36:11-21.